Envista (NYSE:NVST) Downgraded by Zacks Research to Hold

Zacks Research cut shares of Envista (NYSE:NVST) from a strong-buy rating to a hold rating in a research note released on Monday morning,Zacks.com reports.

A number of other research firms have also weighed in on NVST. Weiss Ratings upgraded shares of Envista from a “sell (d)” rating to a “hold (c-)” rating in a research note on Tuesday, February 17th. Barclays increased their price objective on shares of Envista from $24.00 to $34.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 11th. Morgan Stanley set a $19.00 price objective on shares of Envista in a research note on Friday, February 6th. Robert W. Baird set a $30.00 price objective on shares of Envista in a research note on Friday, February 6th. Finally, Wall Street Zen upgraded shares of Envista from a “buy” rating to a “strong-buy” rating in a research note on Monday, January 26th. Seven research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $27.75.

Envista Trading Down 2.2%

NYSE NVST opened at $25.25 on Monday. The stock has a market cap of $4.14 billion, a P/E ratio of 90.16, a P/E/G ratio of 1.76 and a beta of 0.98. Envista has a 12-month low of $14.22 and a 12-month high of $30.42. The company has a fifty day simple moving average of $26.72 and a two-hundred day simple moving average of $23.14. The company has a current ratio of 2.38, a quick ratio of 2.04 and a debt-to-equity ratio of 0.47.

Envista (NYSE:NVST) last released its quarterly earnings data on Thursday, February 5th. The company reported $0.38 earnings per share for the quarter, topping analysts’ consensus estimates of $0.32 by $0.06. Envista had a net margin of 1.73% and a return on equity of 6.54%. Envista’s revenue for the quarter was up 15.0% compared to the same quarter last year. During the same period last year, the company earned $0.24 EPS. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. On average, analysts forecast that Envista will post 1 earnings per share for the current year.

Insider Buying and Selling

In related news, SVP Mischa Reis sold 9,675 shares of the firm’s stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $30.00, for a total transaction of $290,250.00. Following the sale, the senior vice president owned 32,382 shares in the company, valued at approximately $971,460. This trade represents a 23.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.66% of the company’s stock.

Institutional Trading of Envista

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Farther Finance Advisors LLC grew its position in Envista by 317.6% during the third quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock valued at $27,000 after buying an additional 1,026 shares during the period. Caitong International Asset Management Co. Ltd grew its position in Envista by 16,711.1% during the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after buying an additional 1,504 shares during the period. Allworth Financial LP grew its position in shares of Envista by 75.4% in the fourth quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after purchasing an additional 776 shares during the period. UMB Bank n.a. grew its position in shares of Envista by 46.1% in the fourth quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock valued at $44,000 after purchasing an additional 636 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Envista by 73.1% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock valued at $44,000 after purchasing an additional 949 shares during the period.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.